12.2 C
Washington

Eli Lilly could launch obesity drug in India next year | Reuters News Agency

Date:

Share:

Health

Reuters exclusively reported that U.S. drugmaker Eli Lilly LLY.N expects to launch Mounjaro, its blockbuster diabetes drug and wildly popular obesity treatment, in India as early as next year after it clears an ongoing regulatory review. 

Market Impact

The market opportunity is huge in the world’s most populous country, which has high obesity rates, especially among women, and the second-highest number of people with type-2 diabetes globally.

Article Tags

Topics of Interest: Health

Type: Reuters Best

Sectors: Pharmaceuticals & Healthcare

Regions: Asia

Countries: India

Win Types: Exclusivity

Story Types: Exclusive / Scoop

Media Types: Text

Customer Impact: Significant National Story

Source link

Subscribe to our magazine

━ more like this

Video: The Volunteer Groups Preparing for a Post-FEMA World

As the Trump administration threatens to dismantle FEMA, military veterans and other volunteers are preparing to take a bigger role in disaster relief. Emily...

Weight loss jabs study begins after reports of pancreas issues

Getty ImagesA study into potential serious side effects of weight loss jabs has been launched after hundreds of people reported problems with their pancreas....

Access Denied

Access Denied You don't have permission to access "http://www.ndtv.com/business-news/sensex-nifty-jump-in-early-trade-as-tensions-ease-in-middle-east-8755060" on this server. Reference #18.1c0c2d17.1750980844.20843c77 https://errors.edgesuite.net/18.1c0c2d17.1750980844.20843c77 Source link